Thank you for reaching out.
We’ll get back to you shortly.

Thank you for reaching out.
We’ll get back to you shortly.

Contact Us

INSAR 2020, from home

Man working from home office.
Remote possibility: Autism’s biggest annual conference, which moved online due to COVID-19, vied for researchers’ attention with grant writing and other duties.

MoMo Productions / Getty Images

Like so many other events this year, autism’s biggest annual conference — the International Society for Autism Research (INSAR) meeting — was forced to go virtual because of the coronavirus pandemic.

The annual gathering, which had been slated for May in Seattle, Washington, was moved online 3 June. In an ordinary year, Spectrum’s reporters would fan out across the conference center and file at least 20 breaking news stories from the meeting; this year — with the help of you, our readers — we put together a roundup of the meeting’s most exciting and important online presentations from home.

We are grateful to all who contributed their thoughts. Understandably, a fair number of you told us you were too busy with other duties — grant writing, homeschooling and caring for loved ones — to peruse the meeting’s online offerings and 992-page abstract book.

But some of you found time to offer suggestions and thoughts, and to note some important trends: For instance, neuropsychology expert Sven Bölte of the Karolinska Institutet in Stockholm, Sweden, who was one of the meeting’s keynote speakers, noticed a welcome uptick in the number of presentations from scientists working in underrepresented regions, including 31 from African researchers.

Let us know what you think. We will continually update this list with further suggestions.

With all good wishes,

The Spectrum team


The toll of copy number variation
Only a dozen copy number variants — DNA deletions and duplications — are associated with autism, yet many more shape a person’s odds of having the condition. The model in this paper estimates the impact of deletions and duplications on intelligence and autism traits across more than 4,500 genes. Among the findings, the deleterious effect of deletions on intelligence quotient is three times greater than that of duplications; also, deletions and duplications take different tolls on social communication and behavior, but they affect motor skills equally.
Differential effects of deletions and duplications on autism risk across the genome

Upping the list of autism-linked genes
A new genomic analysis of more than 10,000 people with autism and nearly 20,000 of their first-degree relatives bumps the tally of genes associated with the condition from about 100 up to 161. Many of the new genes share functions with known autism-linked genes and are involved with RNA binding, transcriptional regulation and neuronal communication. The analysis also suggests that there is a higher inherited contribution to autism among families with multiple autistic members, compared with those that include only one autistic member.
Genomic analysis of 10,242 individuals with autism spectrum disorder (ASD) recruited online identifies 161 risk genes and new insights into the genetic architecture of multiplex families

Genetic phenotyping
By analyzing the sequences of roughly 200 autism candidate genes in more than 5,000 families in China with an autistic child, researchers have identified new genes that likely contribute to the condition. Some of the families carry inherited changes to genes previously linked to autism by way of spontaneous, or de novo, mutations; many parents in those families show traits of autism or other neurodevelopmental conditions. The findings suggest there are several genetic subtypes of autism linked to specific traits.
Autism high-risk genes and new genetic subtypes

The roots of resilience
Not everyone who harbors genetic mutations linked to autism shows autism traits. A new study begins to offer an explanation for this ‘resilience.’ Researchers analyzed DNA sequences from members of 1,201 families in which one child has autism. They found that about 8 percent of non-autistic parents and siblings carry mutations in established autism genes. What’s more, resilient siblings tend to be girls and to have lower overall genetic ‘risk scores’ for autism, suggesting that a mutation’s effects depend partly on someone’s sex and genetic background.
Differences in the genetic background contribute to risk and resilience to autism


Predicting adult outcomes
If clinicians could predict how children with autism might fare as adults, they could better tailor their support — but it’s no easy task when working with a condition that has such variable outcomes. To compare different forecasting tactics, researchers administered a battery of tests and questionnaires to 123 young adults referred for an autism diagnosis at age 2. They found that trait severity and intelligence quotient best predicted adult outcomes. The metric that best reflected the participants’ subjective well-being — at least for more cognitively able adults — was tallying how many positive milestones, such as having steady employment and friendships, they had met.
Assessing longitudinal adult outcomes: A comparison of three approaches

Restricted and repetitive behaviors over time
A decrease in restricted and repetitive behaviors throughout childhood may forecast positive outcomes in adulthood, according to a study that followed 89 autistic individuals from age 2 to 25. Among autistic adults with an intelligence quotient of 70 or above, those who have at least one good friend, live independently and hold a steady job or attend college showed a significant decrease in verbal repetition and other so-called ‘lower order’ restricted and repetitive behaviors from age 9 to 18. Among autistic adults with an intelligent quotient below 70, a decrease from age 2 to 9 was linked to greater social contact or work outside of the home and daily living skills by age 25.
Adults with autism who achieve different functional outcomes show distinctive trajectories of RRBs from age 2 to 18

Sensory reactivity and communication abilities
Elementary-school-aged children on the spectrum who have sensory issues — sensory hypersensitivity, insensitivity or an unusual interest in sensory stimuli — tend to have poorer adaptive behavior skills later in life than do those without sensory issues. A new study partially extends these findings to infants and toddlers with autism. Among 90 autistic children, those who were most overreactive to sensory stimuli at 12 months of age had the lowest communication skills at 36 months, indicating a possible link between sensory issues and the development of language skills.
Sensory profiles as predictors of adaptive behavior in toddlers with autism

Developmental paths for white matter
White matter, the bundles of nerve fibers that connect brain regions, matures differently in autistic children, a new study confirms. The study involved 135 autistic children and 83 typical controls, who each underwent at least two brain scans from age 2 to 6 and a half years. The researchers found that before 30 to 36 months of age, autistic children’s white matter tends to have more structural integrity than that of controls. By age 6 and a half, however, the opposite is true: Typical children have greater structural integrity than children with autism do.
A longitudinal diffusion weighted imaging study of white matter development in autism across early childhood

Shifts in severity
The severity of autism traits may change more than previously thought, according to a study that followed 169 autistic children from age 3 to 12. Past research has suggested that most children’s autism traits remain stable over time. By contrast, the new work shows that traits tend to wane from age 3 to 6 and increase from age 6 to 12, although the magnitude of those changes varies widely. Children whose traits diminish the most tend to be female and have a high intelligence quotient, superior daily-living skills and high levels of anxiety.
Autism symptom trajectories from early to middle childhood in the children of the Autism Phenome Project

Going through changes
Autistic children’s cognitive and social abilities also shift over time, especially from age 2 to 13, a related study that tracked 90 participants suggests. The researchers divided children into three groups based on changes in their intelligence quotients (IQ) over time: The ‘persistently low’ group, which includes almost half of the children, started out with a below-average IQ that remained low; the ‘persistently high’ group, with about one-quarter of the participants, began the study with an above-average IQ and remained stable; the remaining children all belonged to the ‘positive changers’ group, and started out with a below-average IQ but had significant increases in that measure by adolescence. All three groups showed a decline in social motivation with age, and the ‘persistently high’ group showed an increase in signs of anxiety and depression. But the ‘positive changers’ showed gains in social awareness and functioning, suggesting a link between cognitive development and social skills.
Cognitive developmental trajectories, social functioning, and internalizing psychopathology in preadolescents with ASD

Coordinated actions
Some autistic children have problems with tasks that require coordinating their actions with those of a peer, a study has found. A group of 28 children with autism, aged 6 to 12, and another with 28 autistic adolescents completed two tests of coordinated joint actions: One required the participants to walk side by side with a peer while mirroring their companion’s movements, and the other involved kicking and catching a virtual football. Adolescents tended to perform better than younger children on these tests; performance was best among those with a high IQ, superior fine and gross motor skills, and low levels of autism traits, suggesting that age, motor skills, autism trait severity and IQ contribute to a child’s coordinated joint-action abilities.
Developmental trajectories in coordinated joint action and their link to motor functioning in ASD: Preliminary results


From maternal to child health
A woman’s health during pregnancy contributes to her child’s overall health. So in this study, researchers analyzed medical records of the mothers of nearly 90,000 children in Israel to look at how various diagnoses in the year before conception and throughout pregnancy affect the odds of having a child with autism. The strongest associations, they found, included psychiatric, metabolic and genitourinary conditions.
The etiological relationships between maternal health and autism spectrum disorder

Early diagnosis
Early diagnosis is thought to lead to improved outcomes for autistic children, but to be diagnosed, children must be old enough to show autism traits — something that does not usually happen until around age 2. Brain scans might help doctors detect autism even earlier. In this preliminary study, researchers took two types of brain scans — looking at brain structure and how different brain areas communicate — in babies at 6 and 12 months of age and predicted with 80 percent accuracy which babies would be diagnosed at age 2. The researchers are working to replicate these results in a larger group of children.
The presymptomatic prediction of ASD using infant MRI

A research agenda for autism
Emily Simonoff, professor and head of child and adolescent psychiatry at Kings College London in the United Kingdom, outlined four key priorities for research on psychiatric conditions among autistic people in the coming decade. These include improving the accuracy of tools used to measure and assess mental health issues, developing more effective treatments for them, identifying their underlying mechanisms and building better models to predict who is most likely to have them.
Mental health in autistic people: Setting a research agenda for the coming decade


Pupil responses as a biomarker
A meta-analysis of 32 eye-tracking studies adds support to the idea that people with autism show distinct pupillary responses. Researchers found that, compared with controls, autistic individuals’ pupils tend to be larger at rest and respond differently to stimuli — showing greater arousal in response to nonsocial stimuli than to social stimuli, for example. They also constrict less and more slowly in response to flashes of light. Regardless of whether pupillary responses can be validated as a biomarker, this work suggests that autism involves heightened arousal of the autonomic nervous system and atypical selective attention and information processing.
A meta-analysis of differences in pupillary measures between individuals with and without autism spectrum disorder

Heart health
Though autism is most often thought of as a neurodevelopmental condition, it affects other areas of the body, too, including the heart. To classify its cardiac impact, researchers are examining measures of heart health in 12 mouse models. So far, they’ve linked mutations in the autism genes SHANK3, CHD8 and ARID1B to heart issues, such as alterations in heart rate, wall thickness in the left ventricle and the diameter of the aorta, with more data yet to be analyzed.
Cardiac comorbidities and their effect in autism spectrum disorder

Paying attention to gene variants
Children with mutations in a gene called GRIN2B often have autism, intellectual disability and attention problems. A new study points to a possible brain activity signature for attention problems in these children. Researchers used electroencephalography (EEG) to monitor brain activity in 7 children with GRIN2B mutations, 65 autistic children without mutations in the gene and 77 typical controls. They played a repeating sound and then measured the children’s EEG response when the sound changed. Children with GRIN2B mutations had a larger EEG response to the new sound than did either typical or autistic children without GRIN2B mutations. This suggests that GRIN2B alters brain systems involved in controlling attention.
Connecting brain and behavior: Understanding GRIN2B disruptive mutations

Sensory subgroups
Most autistic people show atypical responses to sensory stimuli, but these responses can vary widely. To get a better handle on this diversity, researchers analyzed the sensory traits of 332 autistic children and adults, using a 38-item questionnaire filled out by parents. They found that the participants could be split into three groups — severe, moderate and low/mild — based on the frequency with which they show seven types of sensory behaviors. Those in the severe group tend to have the most problems with social and communication skills, whereas those in the moderate group tend to show the most signs of anxiety.
Dissecting the phenotypic heterogeneity in sensory behaviours in autism spectrum disorder: A factor mixture modelling approach

Measuring social communication
A widely used tool from the 1970s could serve as a simple and accurate way to assess social-communication skills among autistic children, a new study suggests. The tool, called the Clinical Global Impression – Severity (CGI-S) scale, is designed to measure the overall severity of psychiatric conditions, such as schizophrenia and bipolar disorder. It requires a clinician to rate a person’s trait severity on a scale from 1 to 7, with lower scores indicating less impairment relative to other individuals with the same diagnosis. The scale has never been validated for use with autistic people, though, so researchers tested it with a group of 54 minimally verbal autistic children, who speak few or no words. Children with ratings on the CGI-S from 1 to 5 tend to initiate or respond to bids for joint attention more frequently than do their counterparts with ratings of 6 or 7. The two groups do not differ in the frequency of their restricted and repetitive behaviors, however, suggesting that the scale can accurately measure social communication skills among autistic children.
The Clinical Global Impressions-Severity (CGI-S) Scale: Measuring severity of social communication impairment among minimally verbal children with autism


Biases in play-based interventions
Play-based interventions are widely used to help children with autism develop social skills. This systematic review of studies evaluating play therapies, however, questions whether they are effective. Researchers conducted a ‘risk of bias’ assessment on 76 studies of play therapies and found that 76 percent of them have flaws in their design and execution that could have skewed the results. The researchers highlight the need for improved study designs to evaluate these therapies.
Are play-based interventions for children with autisms spectrum disorder effective?

Stimulating the cerebellum
Jolting the cerebellum with a weak electrical current appears to improve performance on a social-learning task in adults with autism. Researchers used a technique called transcranial direct current stimulation to activate or inhibit cerebellar neurons in 10 adults with autism and 16 typical controls as they played a virtual ball-toss game. Without stimulation, the autistic participants showed less activity in the cerebellum, as measured by functional magnetic resonance imaging, during the task and less social learning than typical participants did. Delivering a current to activate cerebellar neurons impaired social learning in both groups, suggesting that the region helps with the acquisition of social information. A current that inactivated cerebellar neurons, however, improved social learning for the autistic participants.
The cerebellum modulates the acquisition of social information in autism

Oxytocin’s effects
Daily doses of the hormone oxytocin, inhaled through the nose, do not improve sociability in children with autism, according to preliminary results from two new clinical trials. One of the trials, which lasted 24 weeks and was completed by 253 children with autism, found that the children who received oxytocin fared no better than those given placebo, according to a measure of social withdrawal and other tests of social function. The other trial spanned 12 weeks and involved nearly 54 autistic children. It similarly found that oxytocin has no effect on social withdrawal, but hints that the treatment may improve social recognition and ease emotional problems.
A large, heterogenous double-blinded trial of oxytocin to enhance social behaviours in ASD
Randomized controlled trial of intranasal oxytocin in autism spectrum disorder

Anti-brain antibodies
Some mothers of autistic children have antibodies that attack a brain protein called CASPR2. In 2015, researchers showed that injecting pregnant mice with these antibodies can cause their pups to have autism-like traits. Now, the same group has created a new mouse model that better mimics how the antibodies occur in people. They coaxed pregnant mice to make their own antibodies against CASPR2 by injecting them with a piece of the CASPR2 protein. The mice’s offspring show brain changes, repetitive behaviors and social difficulties, some of which the researchers were able to reverse by treating the mice with a drug that impairs brain cells called microglia.
Activation of microglia mediates ASD like phenotype in mice following in utero exposure to anti-CASPR2 antibodies

Shared learning
Autism specialists at 12 centers across North America have pilot-tested a videoconferencing program that allows them to share their expertise and clinical practices with one another — a program that has become even more valuable amid the current pandemic. Most participants reported high satisfaction with the program, which is called the Extension for Community Healthcare Outcomes (ECHO) model, and say that learning from other specialists led to changes in their own clinical practice. “This is an important program that is even more important now, given COVID-19,” says Thomas Frazier, professor of psychology at John Carroll University in University Heights, Ohio.
Novel approach to reducing variability in diagnostic and longitudinal care delivery through Echo Autism: Center Development & Support

related articles

User Pic

Molecular switch marks mosaic mutations in mice

A new tool enables researchers to create mosaic mutations in only some cells and then a...

User Pic

Drug helps mice with autism-linked mutation recognize others

Ion flow: A protein (red) that ferries potassium out of nerve cells abounds in a small ...

User Pic

Beyond the bench: A conversation with Tony Zador

Anthony Zador Professor, Cold Spring Harbor Laboratory When Tony Zador is thinking ab...

User Pic

Pain keeps autistic women and girls home from work, school

Pain report: Many independent adults with autism describe frequent physical discomfort....


google analytics policy

we may collect information about your computer, including your IP address, operating system and browser type, for system administration and in order to create reports. This is statistical data about our users' browsing actions and patters, and does not identify any individual.

The only cookies in use on our site are for Google Analytics. Google Analytis is aweb analytics tool that helps website owners understand how visitors engage with their website. GoogleAnalytics customers can view a variety of reports about how visitors interact with their website so that they can improve it.

Like many services, Google Analytics users first-party cookies to track visitor interactions as in our case, where they are used to collect information about how visitors use our site. We then use the information to compile reports and to help use improve our site.

Cookies contain information that is transferred to your computer's hard drive. These cookies are used to store information, such as the time that the current visit occured, whether the visitor has been to the site before and what site referred the visitor to the web page.

Google Analyticsw collets information anonymously. It reports website trends without identifying individual visitors. you can opt out of Google Analytics without affecting how your visit our site- for more information on opting our of being tracked by Google Analytics across all websites you use, visit this Google page


hipaa privacy

Compleat KiDZ


If you have any questions about this Notice of Privacy Practices, please contact our Privacy Officer, by telephone at (704) 824-7800 or in writing at 2675 Court Drive, Gastonia, NC 28054.
This Notice of Privacy Practices describes how we may use and disclose your protected health information to carry out treatment, payment or health care operations and for other purposes that are permitted or required by law. It also describes your rights to access and control your protected health information. Protected health information is information about you, including demographic information, that may identify you and that relates to your past, present or future physical or mental health or condition and related health care services.


We are required to abide by the terms of this Notice of Privacy Practices. We may change the terms of our Notice of Privacy Practices at any time. The new Notice of Privacy Practices will be effective for all protected health information that we maintain at that time. Upon your request, we will provide you with any revised Notice of Privacy Practices. You may request a revised version by calling or writing our Privacy Officer and requesting that a revised copy be sent to you in the mail or asking for one at the time of your next appointment.


Your protected health information may be used and disclosed by our office staff others outside of our office who are involved in your care and treatment for the purpose of providing health care services to you.
Your protected health information may also be used and disclosed to pay your health care bills and to support the operation of our practice.
Following are examples of the types of uses and disclosures of your protected health information that we are permitted to make. These examples are not meant to be exhaustive, but to describe the types of uses and disclosures that may be made by our office.

1. Treatment: We will use and disclose your protected health information to provide, coordinate, or manage your health care and any related services. This includes the coordination or management of your health care with another provider.
For example, we would disclose your protected health information, as necessary, to a home health agency that provides care to you. We will also disclose protected health information to other healthcare providers who may be treating you.
For example, your protected health information may be provided to a physician to whom you have been referred to ensure that the physician has the necessary information to diagnose or treat you. In addition, we may disclose your protected health information from time-to-time to other health care providers (e.g., a specialist or laboratory) who become involved in your care by providing assistance with your health care diagnosis or treatment to us.
2. Payment: We may use and disclose protected health information about you so that the treatment and services you receive at Compleat KiDZ may be billed to and payment may be collected from you, an insurance company, or a third party. This may include certain activities that your health insurance plan may undertake before it approves or pays for the health care services we recommend for you such as: making a determination of eligibility or coverage for insurance benefits, and reviewing services provided to you for medical necessity. For example, if you have a back injury, we may need to give your health plan information about your condition, supplies used, and services you received.
3. Healthcare Operations: We may use or disclose, as needed, your protected health information for healthcare operations. These uses and disclosures are necessary to run Compleat KiDZ and make sure that all of our patients receive quality care. For example, we ma)'use protected health information to review our treatment and services and to evaluate the performance of our staff in caring for you. We may also combine protected health information about many patients to decide what additional services Compleat KiDZ should offer, what services are not needed, and whether certain new treatments are effective. We may also disclose information to doctors, nurses, technicians, medical students, and other personnel for review and learning purposes, we may remove information that identifies you from this set of protected health information so others may use it to study health care and health care delivery without learning the identities of specific patients.
We may share your protected health information with third party "business associates" that perform various activities (for example, billing or transcription services) for our practice. Whenever an arrangement between our practice and a business associate involves the use or disclosure of your protected health information, we will have a written contract that contains terms that will protect the privacy of your protected health information.
We may use and / or disclose protected health information to contact you to, remind you about an appointment you have for treatment or medical care.
We may use or disclose your protected health information, as necessary, to provide you with information about treatment alternatives or other health--related benefits and services that may be of interest to you. You may contact our Privacy Officer to request that these materials not be sent to you.
4. Other Permitted and Required Uses and Disclosures That May Be Made Without Your Authorization or Opportunity to Agree and Object:
We may use or disclose your protected health information in the following situations without your authorization or providing you the opportunity to agree or object. These situations include:
(i) Required by Law: We may use or disclose your protected health information to the extent that the use or disclosure is required by law. The use or disclosure will be made in compliance with the law and will be limited d to the relevant requirements of the law. You will be notified, if required by law, of any such uses or disclosures.

(ii) Public Health: We may disclose your protected health information for public health activities and purposes to a public health authority that is permitted by law to collect or receive the information. For example, a disclosure may be made for the purpose of preventing or controlling disease, injury or disability.

(iii) Communicable Diseases: We may disclose your protected health information, if authorized by law, to a person who may have been exposed to a communicable disease or may otherwise be at risk of contracting or spreading the disease or condition.

(iv) Health Oversight: We may disclose protected health information to a health oversight agency for activities authorized by law, such as audits, investigations, and inspections. Oversight agencies seeking this information include government agencies t-rat oversee the health care system, government benefit programs, other government regulatory programs and civil rights laws.

(v) Abuse or Neglect: We may disclose your protected health information to a public health authority that is authorized by law to receive reports of child abuse or neglect. In addition, we may disclose your protected health information if we believe that you have been a victim of abuse, neglect or domestic violence to the governmental entity or agency authorized to receive such information. In this case, the disclosure will be made consistent with the requirements of applicable federal and state laws.

(vi) Legal Proceedings: We may disclose protected health information in the course of any judicial or administrative proceeding, in response to an order of a court or administrative tribunal (to the extent such disclosure is expressly authorized), or in certain conditions in response to a subpoena, discovery request or other lawful process.

(vii) Law Enforcement: We may also disclose protected health information, so long as applicable legal requirements are met, for law enforcement purposes, these law enforcement purposes include (1) legal processes and otherwise required by law, (2) limited information requests for identification and location purposes, (3) pertaining to victims of a crime, (4) suspicion that death has occurred as a result of criminal conduct, (5) in the event that a crime occurs on the premises of our practice, and (6) medical emergency (not on our premises) and it is likely that a crime has occurred.

(viii) Research: We may disclose your protected health information to researchers when their research has been approved by an institutional review board that has reviewed the research proposal and established protocols to ensure the privacy of your protected health information.

(ix) Criminal Activity: Consistent with applicable federal and state laws, we may disclose your protected health information, if we believe that the use or disclosure is necessary to prevent or lessen a serious and imminent threat to the health or safety of a person or the public. We may also disclose protected health information if it is necessary for law enforcement authorities to identify or apprehend an individual.

(x) Military Activity and National Security: When the appropriate conditions apply, we may use or disclose protected health information of individuals who are Armed Forces personnel (1) for activities deemed necessary by appropriate military command authorities; (2) for the purpose of a determination by the Department of Veterans Affairs of your eligibility for benefits, or (3) to foreign military authority if you are a member of that foreign military services. We may also disclose your protected health information to authorized federal officials for conducting national security and intelligence activities, including for the provision of protective services to the President or others legally authorized.

(xi) Workers' Compensation: We may disclose your protected health information as authorized to comply with workers' compensation laws and other similar legally established programs.
5. Other Permitted and Required Uses of Disclosures That Require Providing You the Opportunity to Agree or Object
We may use and disclose your protected health information in the following instances. You have the opportunity to agree or object to the use or disclosure of all or part of your protected health information. If you are not present or able to agree or object to the use or disclosure of the protected health information, then we may, using professional judgment, determine whether the disclosure is in your best interest.

Others Involved in Your Health Care or Payment for our Care:

Unless you object, we may disclose to a member of your family, a relative, a close friend or any other person you identify, your protected health information that directly relates to that person's involvement in your health care. If you are unable to agree or object to such a disclosure, we may disclose such information as necessary if we determine that it is in your best interest based on our professional judgment. We may use or disclose protected health information to notify or assist in notifying a family member, personal representative or any other person that is responsible for your care of your location, general condition or death. Finally, we may use or disclose your protected health information to an authorized public or private entity to assist in disaster relief efforts and to coordinate uses and disclosures to family or other individuals involved in your health care.
6. Uses and Disclosures of Protected Health Information Based upon Your Written Authorization Other uses and disclosures of your protected health information will be made only with your written authorization, unless otherwise permitted or required by law as described below. You may revoke this authorization in writing at any time. If you revoke your authorization, we will no longer use or disclose your protected health information for the reasons covered by your written authorization. Please understand that we are unable to take back any disclosures already made with your authorization.
Following is a statement of your rights with respect to your protected health information and a brief description of how you may exercise these rights
1. You have the right to inspect and copy your protected health information
This means you may inspect and obtain a copy of protected health information about you for so long as we maintain the protected health information. You may obtain your medical record that contains medical and billing records and any other records that we use for making decisions about you. As permitted by federal or state law, we may charge you a reasonable copy fee for a copy of your records.
2. You have the right to request a restriction of your protected health information
This means you may ask us not to use or disclose any part of your protected health information for the purposes of treatment, payment or health care operations. You may also request that any part of your protected health information not be disclosed to family members or friends who may be involved in your care or for notification purposes as described in this Notice of Privacy Practices. Your request must state the specific restriction requested and to whom you want the restriction to apply.

We are not required to agree to a restriction that you may request. If we agree to the requested restriction, we may not use or disclose your protected health information in violation of that restriction unless it is needed to provide emergency treatment. With this in mind, please discuss any restriction you wish to request with your health provider.

You may request a restriction by making your request in writing to our Privacy Officer. In your request, you must tell us (1) what information you want to limit; (2) whether you want to limit our use, disclosure, or both; and (3) to whom you want the limits to apply, for example, disclosures to your spouse.
3. You have the right to request to receive confidential communications from us by alternative means or at an alternative location
We will accommodate reasonable requests. We may also condition this accommodation by asking you for information as to how payment will be handled or specification of an alternative address or other method of contact. We will not request an explanation from you as to the basis for the request. Please make this request in writing to our Privacy Officer.
4. Your may have right to amend your protected health information
This means you may request an amendment of protected health information about you in a designated record set for so long as we maintain this information. In certain cases, we may deny your request for an amendment. If we deny your request for amendment, you have the right to file a statement of disagreement with us and we may prepare a rebuttal to your statement and will provide you with a copy of any such rebuttal. Please contact our Privacy Officer if you have questions about amending your medical record.
5. You have the right to receive an accounting of certain disclosures we have made, if any, of your protected health information This right applies to disclosures for purposes other than treatment, payment or health care operations as described in this Notice of Privacy Practices. It excludes disclosures we may have made to you if you authorized us to make the disclosure, to family members or friends involved in your care, or for notification purposes, for national security or intelligence, to law enforcement (as provided in the privacy rule) or correctional facilities, as part of a limited data set disclosure. The right to receive this information is subject to certain exceptions, restrictions and limitations.
6. You have the right to obtain a paper copy of this notice from us
upon request, even if you have agreed to accept this notice electronically.
You may complain to us or to the Secretary of Health and Human Services if you believe your privacy rights have been violated by us. You may file a complaint with us by notifying our Privacy Officer of your complaint. We will not retaliate against you for filing a complaint

You may contact our Privacy Officer at (704) 824-7800 for further information about the complaint process.

This notice was published and becomes effective on August l, 2011.